Evaluation of the Potential Drug-Drug Interaction Between Aspirin and Fexuprazan in Healthy Subjects Using Mechanism-Based PK/PD Modeling
Abstract
Background and objective : Long-term aspirin therapy requires gastroprotection with acid suppressants such as fexuprazan, a novel potassium-competitive acid blocker (P-CAB), which raises theoretical concerns about altered absorption kinetics due to elevated gastric pH. This study aimed to quantitatively evaluate the potential drug-drug interaction (DDI) between aspirin and fexuprazan using a mechanism-based pharmacokinetic/pharmacodynamic (PK/PD) modeling approach.Methods : A mechanism-based PK/PD model was developed using clinical data from healthy subjects administered a single oral dose of aspirin (500 mg) alone or in combination with fexuprazan (80 mg). The model linked fexuprazan-induced intragastric pH dynamics to the absorption kinetics of aspirin and its subsequent irreversible inhibition of platelet aggregation. Based on this established model, simulations were performed to predict the PK and PD profiles of clinically relevant low-dose aspirin (100 mg) combined with therapeutic maintenance doses of fexuprazan (20 mg and 40 mg).Results: Fexuprazan co-administration elevated gastric pH, which slightly delayed the absorption rate of aspirin. However, it did not significantly alter the total systemic exposure () of aspirin or its major metabolite, salicylic acid. Regarding pharmacodynamics, a minor statistical difference was observed for the high-dose regimen. However, simulations predicted that the antiplatelet efficacy of low-dose aspirin would remain virtually…
Read the paper
Related studies
- Temporal profiles of viral load in posterior oropharyngeal saliva samples and serum antibody responses during infection by SARS-CoV-2: an observational cohort study
- Treatment and prognostic factors for long-term outcome in patients with anti-N-Methyl-D-Aspartate (NMDA) receptor encephalitis: a cohort study
- Effectiveness of mRNA BNT162b2 COVID-19 vaccine up to 6 months in a large integrated health system in the USA: a retrospective cohort study
- Postsurgical prescriptions for opioid naive patients and association with overdose and misuse: retrospective cohort study
- Ethnic and socioeconomic differences in SARS-CoV-2 infection: prospective cohort study using UK Biobank
- Timing of high-efficacy therapy for multiple sclerosis: a retrospective observational cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.